Literature DB >> 24642721

The common single-nucleotide polymorphism rs2681472 is associated with early-onset preeclampsia in Northern Han Chinese women.

Ji-Peng Wan1, Hong Wang1, Chang-Zhong Li1, Han Zhao2, Li You2, Dong-Hong Shi1, Xiu-Hua Sun3, Hong Lv1, Fei Wang1, Ze-Qing Wen1, Xie-Tong Wang4, Zi-Jiang Chen2.   

Abstract

Preeclampsia, characterized by hypertension and proteinuria, remains a leading cause of maternal morbidity and mortality. Recently, a genome-wide association study (GWAS) identified the single-nucleotide polymorphism, rs2681472, as a new hypertension susceptibility genetic variant. The purpose of this study was to evaluate the association between preeclampsia and rs268172 in a Northern Han Chinese population. We genotyped 1218 unrelated Northern Han Chinese women, including 515 patients with preeclampsia and 703 healthy controls. No significant differences were detected in the allele frequencies between patients and controls (P = .23). When patients were divided into early-onset and late-onset preeclampsia according to gestational age of disease onset, the allele frequencies significantly differed between controls and patients with early-onset preeclampsia (P = .02). Genotype frequencies also were significantly different between controls and patients early-onset preeclampsia when data were analyzed under additive (P = .03) and dominant (P = .009) models. We replicated this association in an independent Northern Han Chinese population and observed a significant difference in the allele frequencies between patients with early-onset preeclampsia and controls (P = .011). We report that rs2681472 is associated with early-onset preeclampsia in Northern Han Chinese women.
© The Author(s) 2014.

Entities:  

Keywords:  ATP2B1; genetics; polymorphisms; preeclampsia

Mesh:

Substances:

Year:  2014        PMID: 24642721      PMCID: PMC4212332          DOI: 10.1177/1933719114527354

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  23 in total

1.  Comparative study of the calcium adenosine triphosphatase of basal membranes of human placental trophoblasts from normotensive and preeclamptic pregnant women.

Authors:  Y Casart; T Proverbio; R Marín; F Proverbio
Journal:  Gynecol Obstet Invest       Date:  2001       Impact factor: 2.031

2.  ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

3.  Preeclampsia and calcium adenosine triphosphatase activity of red blood cell ghosts.

Authors:  G Nardulli; F Proverbio; F G Limongi; R Marín; T Proverbio
Journal:  Am J Obstet Gynecol       Date:  1994-11       Impact factor: 8.661

4.  Plasma and membrane Ca2+ and Mg2+ concentrations in normal pregnancy and in preeclampsia.

Authors:  K Kisters; J Körner; F Louwen; R Witteler; C Jackisch; W Zidek; S Ott; G Westermann; M Barenbrock; K H Rahn
Journal:  Gynecol Obstet Invest       Date:  1998       Impact factor: 2.031

5.  Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells.

Authors:  Joern R Steinert; Amanda W Wyatt; Lucilla Poston; Ron Jacob; Giovanni E Mann
Journal:  FASEB J       Date:  2002-03-26       Impact factor: 5.191

6.  Genetic effects on the liability of developing pre-eclampsia and gestational hypertension.

Authors:  H Salonen Ros; P Lichtenstein; L Lipworth; S Cnattingius
Journal:  Am J Med Genet       Date:  2000-04-10

7.  Preeclampsia and calcium-ATPase activity of red cell ghosts from neonatal and maternal blood.

Authors:  Milagros M Carreiras; Teresa Proverbio; Fulgencio Proverbio; Reinaldo Marín
Journal:  Hypertens Pregnancy       Date:  2002       Impact factor: 2.108

8.  Common variants in the ATP2B1 gene are associated with hypertension and arterial stiffness in Chinese population.

Authors:  Yan Wang; Yi Zhang; Yan Li; Xueya Zhou; Xiaofeng Wang; Pingjin Gao; Li Jin; Xuegong Zhang; Dingliang Zhu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

9.  Preeclampsia and calcium-ATPase activity of plasma membranes from human myometrium and placental trophoblast.

Authors:  Francisco Carrera; Ysabel C Casart; Teresa Proverbio; Fulgencio Proverbio; Reinaldo Marín
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

10.  Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension.

Authors:  Katsuhiko Kohara; Yasuharu Tabara; Jun Nakura; Yutaka Imai; Takayoshi Ohkubo; Akira Hata; Masayoshi Soma; Tomohiro Nakayama; Satoshi Umemura; Nobuhito Hirawa; Hirotsugu Ueshima; Yoshikuni Kita; Toshio Ogihara; Tomohiro Katsuya; Norio Takahashi; Katsushi Tokunaga; Tetsuro Miki
Journal:  Hypertens Res       Date:  2008-02       Impact factor: 3.872

View more
  4 in total

1.  A review of omics approaches to study preeclampsia.

Authors:  Paula A Benny; Fadhl M Alakwaa; Ryan J Schlueter; Cameron B Lassiter; Lana X Garmire
Journal:  Placenta       Date:  2020-01-22       Impact factor: 3.481

2.  Interaction between Single Nucleotide Polymorphism and Urinary Sodium, Potassium, and Sodium-Potassium Ratio on the Risk of Hypertension in Korean Adults.

Authors:  Yeong Mi Park; Chang Keun Kwock; Kyunga Kim; Jihye Kim; Yoon Jung Yang
Journal:  Nutrients       Date:  2017-03-05       Impact factor: 5.717

3.  Evidence for the placenta-brain axis: multi-omic kernel aggregation predicts intellectual and social impairment in children born extremely preterm.

Authors:  Hudson P Santos; Arjun Bhattacharya; Robert M Joseph; Lisa Smeester; Karl C K Kuban; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Mol Autism       Date:  2020-12-11       Impact factor: 7.509

4.  Exploration of CYP21A2 and CYP17A1 polymorphisms and preeclampsia risk among Chinese Han population: a large-scale case-control study based on 5021 subjects.

Authors:  Bo Hou; Xuewen Jia; Ziwen Deng; Xin Liu; Huitang Liu; Haichu Yu; Shiguo Liu
Journal:  Hum Genomics       Date:  2020-09-25       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.